Skip to main content

TCG — Portfolio, Page 3

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

147
Companies
$1.7B
Total invested
$31.7M
Avg. check
42
Industries
Biotechnology 11Health Care 9Therapeutics 6Medical 4Pharmaceutical 4Blockchain 3+36 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 4972 of 147
The Pro's Closet
January 2024

The Pro's Closet is a re-Commerce company that specializes in premium pre-owned bike and bike component sales.

Cycling · Boulder$20.1M Venture - Series Unknown
Wthn
January 2024

Wthn is a natural wellness brand offering herbal medicine and acupuncture treatments.

Health Care · New York$5.0M Series A
Medallion
December 2023

Medallion develops a blockchain-based platform to connect artists and their fans.

Blockchain · New York$13.7M Series A
Alkeus Pharmaceuticals
June 2023

Alkeus Pharmaceuticals is a Boston-based startup focused on treatments for serious ophthalmic conditions.

Biotechnology · Cambridge$150.0M Series B
The Sill
January 2024

The Sill offers ceramic planters potted with houseplants.

Consumer Goods · New York$158K Equity Crowdfunding
Beacon Therapeutics
January 2026

Beacon Therapeutics is a biotechnology company that develops treatments to preserve and restore vision for rare and prevalent eye diseases.

Biotechnology · Alachua$75.0M Series C
Century Therapeutics
January 2026

Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.

Biotechnology · Philadelphia$135.0M Post-IPO Equity
Aviceda Therapeutics
January 2025

Aviceda Therapeutics is a late-stage pre-clinical biotech company developing drugs for treating glyco-immune diseases.

Biotechnology · Cambridge$207.5M Series C
Synthekine
January 2023

Synthekine is a development stage biotherapeutics company focused on the engineering of novel specific and potent cytokine therapies.

Biotechnology · Menlo Park$100.0M Series C
Cars & Bids
January 2023

Cars & Bids is an online auction marketplace to buy and sell modern enthusiast cars.

Automotive · San Diego$37.0M Series A
Tourmaline Bio
January 2024

Tourmaline Bio is a biotechnology company that develops medicines to treat inflammatory and immune diseases in patients.

Biotechnology · New York$172.5M Post-IPO Equity
Epic Gardening
December 2021

Our mission is to teach the world to grow.

Home and Garden · San Diego$17.5M Series A
Athira Pharma
December 2025

Athira Pharma is a clinical stage drug development company that specializes in biotechnology and pharmaceutical.

Biotechnology · Seattle$90.0M Post-IPO Equity
Found
December 2021

Found is dedicated to improving people’s overall wellbeing by making evidence-based weight loss accessible and affordable.

Fitness · San Francisco$100.0M Series B
CG Oncology
December 2024

CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.

Biotechnology · Irvine$238.0M Post-IPO Equity
Immunovant
December 2025

Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases.

Biopharma · New York$550.0M Post-IPO Equity
Men In Blazers
January 2025

Men In Blazers is a soccer-focused media company that covers sports events, leagues, and TV shows.

Broadcasting · New York$15.0M Series A
Oncyber
January 2022

Cyber is a metaverse company that lets artists and collectors construct and sell their 3D virtual showrooms for non-fungible tokens(NFTs).

3D Technology · New York$6.7M Seed
Dave
January 2026

Dave is a banking app that offers customers banking, financial insights, overdraft protection, and building credit products.

Banking · Los AngelesUndisclosed
DOOMSDAYX
January 2022

DOOMSDAYX is a creative technology studio for web3 artists and fans, focused on redefining culture on-chain.

Media and Entertainment · Los Angeles$1.5M Pre-Seed
POAP
January 2022

POAP: "Proof of Attendance Protocol. The ecosystem to preserve life experiences as digital collectibles.

Blockchain · New York$10.0M Seed
Alpine Immune Sciences
November 2023

Alpine Immune Sciences is an immunotherapy company focused on developing treatments for autoimmune and inflammatory diseases.

Biotechnology · Seattle$150.0M Post-IPO Equity
Cogent Biosciences
November 2025

Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.

Biotechnology · Waltham$200.0M Post-IPO Debt
Outdefine
October 2023

Outdefine -- The Learning and Execution Layer For Healthcare Systems.

Generative AI · San Francisco$2.8M Seed

Where TCG invests

Biotechnology11
Health Care9
Therapeutics6
Medical4
Pharmaceutical4
Blockchain3

About TCG's portfolio

How many companies has TCG invested in?

TCG has invested in 147 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does TCG invest in?

TCG's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 42 different industry categories.

What is TCG's largest investment?

Among tracked funding rounds, Immunovant received $550.0M in a Post-IPO Equity round. TCG's total known invested capital is $1.7B.

What is the average investment size for TCG?

TCG's average investment size is $31.7M across its portfolio of 147 companies.

What are TCG's most recent investments?

Recent TCG portfolio additions include The Pro's Closet, Wthn, Medallion, Alkeus Pharmaceuticals, The Sill. These companies were founded in 2020 or later.

Reach the founders behind these 147 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →